Projects

A 3-arm, open-label, stratified randomized controlled trial with blinded end-point assessment to EValuate A Nitric oxidE generator (Nebivolol) as a diSease modifying mediCatioN in Diabetic Peripheral Neuropathy. (EVANESCENT-DPN RCT)

Project Duration

2024 - 2026

Project Lead

Dr. Belinda George

Authors

Dr. Belinda

Project Status

ongoing

Project Type

ICMR